← Back to Clinical Trials
Recruiting NCT06221943

NCT06221943 Effectiveness of Caregiver-involved Group-based NDBIs Intervention for Autistic Preschoolers

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06221943
Status Recruiting
Phase
Sponsor National Taiwan University Hospital
Condition Autism Spectrum Disorder
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2024-01-01
Primary Completion 2024-12-31

Eligibility & Interventions

Sex All sexes
Min Age 2 Years
Max Age 6 Years
Study Type INTERVENTIONAL
Interventions
Group-based Naturalistic Developmental Behavioral InterventionOne-on-one Naturalistic Developmental Behavioral InterventionASD Diagnosis

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2024-01-01 with a primary completion date of 2024-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This is a study that investigate the effectiveness of NDBIs for autistic preschoolers delivered in group-settings and one-on-one settings. The outcome measures assess the improvements in autistic symptoms, social communication, play skills, group behaviors, adaptation, and parent stress.

Eligibility Criteria

Inclusion Criteria: * clinically diagnosed as Autism Spectrum Disorder * aged 2-6 years old * one of caregivers is able to participate treatment sessions. Exclusion Criteria: * having other major diseases.

Contact & Investigator

Central Contact

Guan-Jye Seng, M.S.

✉ sophiasft@gmail.com

📞 +886-5-5323911

Frequently Asked Questions

Who can join the NCT06221943 clinical trial?

This trial is open to participants of all sexes, aged 2 Years or older, up to 6 Years, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06221943 currently recruiting?

Yes, NCT06221943 is actively recruiting participants. Contact the research team at sophiasft@gmail.com for enrollment information.

Where is the NCT06221943 trial being conducted?

This trial is being conducted at Douliu, Taiwan.

Who is sponsoring the NCT06221943 clinical trial?

NCT06221943 is sponsored by National Taiwan University Hospital. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology